{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:02:35Z","timestamp":1781712155814,"version":"3.54.5"},"reference-count":90,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,3,1]]},"abstract":"<jats:p>Contraception remains an important part of national efforts to reduce adolescent pregnancy in the United States. A number of safe and effective contraceptive methods are available for our youth, including abstinence, barrier methods, oral contraceptives, Depo-Provera, and Norplant. Research over the past few decades has resulted in a variety of oral contraceptives with reduced amounts of hormones and reduced side-effects. A number of methods have received approval by the Food and Drug Administration since the last review in 1980, including emergency contraceptives, depomedroxyprogesterone acetate, and the cervical cap. The use of condoms and vaginal spermicides continues to be recommended for all sexually active adolescents to reduce (not eliminate) the risk for acquiring sexually transmitted diseases. A polyurethane condom is now available, in addition to the latex condom and other barrier contraceptives, including the following: diaphragm, cervical cap, vaginal sponge, female condom and vaginal spermicides. Because of continuing concerns about pelvic inflammatory disease related to intrauterine devices, currently available intrauterine devices are not recommended for most adolescents. Abortion is not considered as a contraceptive method.<\/jats:p>","DOI":"10.1542\/peds.107.3.562","type":"journal-article","created":{"date-parts":[[2004,8,13]],"date-time":"2004-08-13T23:55:51Z","timestamp":1092441351000},"page":"562-573","source":"Crossref","is-referenced-by-count":35,"title":["Contraception in the Adolescent: An Update"],"prefix":"10.1542","volume":"107","author":[{"given":"Donald E.","family":"Greydanus","sequence":"first","affiliation":[{"name":"From the Department of Pediatrics and Human Development, College of Human Medicine, and Kalamazoo Center for Medical Studies, Michigan State University Kalamazoo, Michigan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilip R.","family":"Patel","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics and Human Development, College of Human Medicine, and Kalamazoo Center for Medical Studies, Michigan State University Kalamazoo, Michigan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Ellen","family":"Rimsza","sequence":"additional","affiliation":[{"name":"Arizona State University, Tempe, Arizona; and the Mayo Graduate School of Medicine, Rochester, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2001,3,1]]},"reference":[{"key":"2021121009361771000_B1","first-page":"87","article-title":"Sexually transmitted diseases, unintended pregnancy, and adolescent health promotion.","volume":"10","author":"Santelli","year":"1999","journal-title":"Adolescent Medicine"},{"key":"2021121009361771000_B2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.65.1.1","article-title":"Contraception in the adolescent: Current concepts for the pediatrician.","volume":"65","author":"Greydanus","year":"1980","journal-title":"Pediatrics"},{"key":"2021121009361771000_B3"},{"key":"2021121009361771000_B4"},{"key":"2021121009361771000_B5"},{"key":"2021121009361771000_B6","first-page":"1S","article-title":"The power of the pill.","volume":"59","author":"Mishell","year":"1999","journal-title":"Contraception"},{"key":"2021121009361771000_B7","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1542\/pir.19-12-409","article-title":"Providing effective reproductive health care and prescribing contraceptives for adolescents.","volume":"19","author":"Stevens-Simon","year":"1998","journal-title":"Pediatrics Rev"},{"key":"2021121009361771000_B8","first-page":"1","article-title":"American College of Obstetrics and Gynecology. Safety of oral contraceptives for teenagers.","volume":"90","author":"Committee on Adolescent Health Care","year":"1991","journal-title":"ACOG Committee Opinion"},{"key":"2021121009361771000_B9"},{"key":"2021121009361771000_B10","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1001\/jama.279.19.1529","article-title":"Abstinence and safer sex: HIV interventions for African Americans.","volume":"279","author":"Jemmott","year":"1998","journal-title":"JAMA"},{"key":"2021121009361771000_B11","first-page":"1034","article-title":"Evaluation of a new generation of oral contraceptives.","volume":"81","author":"Speroff","year":"1993","journal-title":"Obstet Gynecol"},{"key":"2021121009361771000_B12","first-page":"211","article-title":"An update for contraception for adolescents.","volume":"10","author":"Brooks","year":"1999","journal-title":"Adolesc Med"},{"key":"2021121009361771000_B13","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1001\/archpedi.1997.02170400076014","article-title":"Sexual health contraceptive needs of adolescents with chronic conditions.","volume":"151","author":"Blum","year":"1997","journal-title":"Arch Pediatr Adolesc Med"},{"key":"2021121009361771000_B14"},{"key":"2021121009361771000_B15","first-page":"121","article-title":"Oral contraceptives and cardiovascular events: Summary and application of data.","volume":"45","author":"Mishell","year":"2000","journal-title":"Int J Fertil"},{"key":"2021121009361771000_B16","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0002-9378(99)70182-1","article-title":"Estimates of the risk of cardiovascular death attributable to low-dose oral contraceptives in the United States.","volume":"180","author":"Schwingel","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"2021121009361771000_B17","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(95)91927-9","article-title":"Effect of different progestagens in low estrogen oral contraceptives on venous thromboembolic disease.","volume":"346","author":"World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception","year":"1995","journal-title":"Lancet"},{"key":"2021121009361771000_B18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/bmj.312.7023.83","article-title":"Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study.","volume":"312","author":"Sitzer","year":"1996","journal-title":"BMJ"},{"key":"2021121009361771000_B19","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0140-6736(95)91929-5","article-title":"Enhancement of factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third- generation progestagen.","volume":"346","author":"Bloemenkamp","year":"1995","journal-title":"Lancet"},{"key":"2021121009361771000_B20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/jwh.1997.6.49","article-title":"The Nurses Health Study: 20-year contribution to the understanding of health among women.","volume":"6","author":"Colditz","year":"1997","journal-title":"J Womens Health"},{"key":"2021121009361771000_B21","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJM199305273282108","article-title":"Hormonal contraception.","volume":"328","author":"Baird","year":"1993","journal-title":"N Engl J Med"},{"key":"2021121009361771000_B22","first-page":"10","article-title":"Contraception for women with diabetes.","volume":"11","author":"Grimes","year":"2000","journal-title":"The Contraception Report"},{"key":"2021121009361771000_B23"},{"key":"2021121009361771000_B24","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jama.1986.03380020100031","article-title":"Use of oral contraceptives by women with epilepsy.","volume":"256","author":"Mattison","year":"1986","journal-title":"JAMA"},{"key":"2021121009361771000_B25","first-page":"443","article-title":"Should adolescents have over-the-counter access to oral contraceptive pills and antibiotics?","volume":"8","author":"Hewitt","year":"1997","journal-title":"Adolesc Med"},{"key":"2021121009361771000_B26","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0190-9622(94)70127-X","article-title":"A practical approach to antibiotic treatment in women taking oral contraceptives.","volume":"30","author":"Miller","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"2021121009361771000_B27"},{"key":"2021121009361771000_B28","first-page":"134","article-title":"Oral contraceptives and noncontraceptive benefits: Summary and application of data.","volume":"45","author":"Burkman","year":"2000","journal-title":"Int J Fertil"},{"key":"2021121009361771000_B29","first-page":"1713","article-title":"Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data of 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies.","volume":"237","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"1996","journal-title":"Lancet"},{"key":"2021121009361771000_B30","first-page":"113","article-title":"Oral contraceptives and breast cancer risk: summary and application of data.","volume":"45","author":"Speroff","year":"2000","journal-title":"Int J Fertil"},{"key":"2021121009361771000_B31","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJM198903233201206","article-title":"Contraception.","volume":"320","author":"Mishell","year":"1989","journal-title":"N Engl J Med"},{"key":"2021121009361771000_B32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/ije\/24.1.19","article-title":"Combined oral contraceptives and risk of cervical carcinoma in situ.","volume":"24","author":"Ye","year":"1995","journal-title":"Int J Epidemiol"},{"key":"2021121009361771000_B33","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0029-7844(97)00059-8","article-title":"Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized placebo controlled trial.","volume":"89","author":"Redmond","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"2021121009361771000_B34","first-page":"5","article-title":"The health benefits and noncontraceptive uses of oral contraceptives. Adolescent Health Update.","volume":"4","author":"Budow","year":"1992","journal-title":"Pediatrics"},{"key":"2021121009361771000_B35","doi-asserted-by":"crossref","first-page":"S343","DOI":"10.1016\/S0002-9378(99)70694-0","article-title":"Benefits and risks of oral contraceptives.","volume":"180","author":"Sherif","year":"1999","journal-title":"Am J Obstet Gynec"},{"key":"2021121009361771000_B36","first-page":"4","article-title":"Health benefits of oral contraceptives; emergency contraception options.","volume":"8","author":"Grimes","year":"1997","journal-title":"Contraceptive Report"},{"key":"2021121009361771000_B37"},{"key":"2021121009361771000_B38","first-page":"529","article-title":"Functional ovarian cysts in relation to the use of monophasic and triphasic oral contraceptives.","volume":"79","author":"Holt","year":"1992","journal-title":"Obstet Gynecol"},{"key":"2021121009361771000_B39","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1001\/jama.1987.03390240083028","article-title":"Adolescents' compliance with the use of oral contraceptives.","volume":"257","author":"Emans","year":"1987","journal-title":"JAMA"},{"key":"2021121009361771000_B40","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2307\/2991665","article-title":"Compliance, counseling and satisfaction with oral contraceptives: a prospective evaluation.","volume":"39","author":"Rosenberg","year":"1998","journal-title":"Fam Plann Perspect"},{"key":"2021121009361771000_B41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0010-7824(94)90113-9","article-title":"Progestin-only contraception: a comprehensive review.","volume":"50","author":"McCann","year":"1994","journal-title":"Contraception"},{"key":"2021121009361771000_B42","first-page":"455","article-title":"Emergency contraceptives.","volume":"8","author":"Gold","year":"1997","journal-title":"Adolesc Med"},{"key":"2021121009361771000_B43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJM199807023390108","article-title":"Self-administered emergency contraception\u2013a second chance.","volume":"339","author":"Stubblefield","year":"1998","journal-title":"N Engl J Med"},{"key":"2021121009361771000_B44","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1056\/NEJM199807023390101","article-title":"The effect of self-administered emergency contraception.","volume":"339","author":"Glasier","year":"1998","journal-title":"N Engl J Med"},{"key":"2021121009361771000_B45","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2307\/2953348","article-title":"Emergency contraception: a national survey of adolescent health experts.","volume":"29","author":"Gold","year":"1997","journal-title":"Fam Plann Perspect"},{"key":"2021121009361771000_B46","first-page":"439","article-title":"New contraceptive options for adolescents.","volume":"23","author":"Neal","year":"1997","journal-title":"Comprehensive Therapy"},{"key":"2021121009361771000_B47","first-page":"1","article-title":"An emergency contraceptive kit.","volume":"40","author":"The Medical Letter, Inc","year":"1998","journal-title":"Med Lett Drugs Ther"},{"key":"2021121009361771000_B48","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1056\/NEJM199210083271501","article-title":"Mifepristone (RU 486) compared with high dose estrogen and progestogen for emergency postcoital contraception.","volume":"327","author":"Glasier","year":"1992","journal-title":"N Engl J Med"},{"key":"2021121009361771000_B49","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2307\/2136156","article-title":"Contraceptive efficacy of the diaphragm, the sponge, and the cervical cap.","volume":"25","author":"Trussell","year":"1993","journal-title":"Fam Plann Perspect"},{"key":"2021121009361771000_B50","first-page":"9","article-title":"Future barrier methods.","volume":"8","author":"Grimes","year":"1997","journal-title":"The Contraception Report"},{"key":"2021121009361771000_B51","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.2105\/AJPH.84.12.1960","article-title":"Contraceptive efficacy and acceptability of the female condom.","volume":"84","author":"Farr","year":"1994","journal-title":"Am J Public Health"},{"key":"2021121009361771000_B52"},{"key":"2021121009361771000_B53","doi-asserted-by":"crossref","first-page":"910","DOI":"10.2105\/AJPH.84.6.910","article-title":"The use of nonoxynol-9 for protection against cervical gonorrhea.","volume":"84","author":"Weir","year":"1994","journal-title":"Am J Public Health"},{"key":"2021121009361771000_B54","doi-asserted-by":"crossref","first-page":"272","DOI":"10.2307\/2991537","article-title":"The effectiveness of condoms in reducing heterosexual transmission of HIV.","volume":"31","author":"Davis","year":"1999","journal-title":"Fam Plann Perspect"},{"key":"2021121009361771000_B55","first-page":"746","article-title":"Adolescents and condom use.","volume":"147","author":"Joffe","year":"1994","journal-title":"Am J Dis Child"},{"key":"2021121009361771000_B56","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1542\/peds.95.2.281","article-title":"Condom availability for youth.","volume":"95","author":"Committee on Adolescence","year":"1995","journal-title":"Pediatrics"},{"key":"2021121009361771000_B57","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1542\/peds.91.5.873","article-title":"Factors associated with condom use by sexually active male adolescents at risk for sexually transmitted diseases.","volume":"91","author":"Orr","year":"1993","journal-title":"Pediatrics"},{"key":"2021121009361771000_B58","first-page":"449","article-title":"Condom availability in high schools.","volume":"8","author":"Fortenberry","year":"1997","journal-title":"Adolesc Med"},{"key":"2021121009361771000_B59","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2307\/2991662","article-title":"Impact of a high school condom availability program on sexual attitudes and behaviors.","volume":"39","author":"Schuster","year":"1998","journal-title":"Fam Plann Perspect"},{"key":"2021121009361771000_B60","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1054-139X(98)00133-5","article-title":"Partner condom use among adolescent girls with sexually transmitted diseases.","volume":"24","author":"Shrier","year":"1999","journal-title":"J Adolesc Health"},{"key":"2021121009361771000_B61","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0010-7824(96)00003-0","article-title":"The male polyurethane condom: a review of current knowledge.","volume":"53","author":"Rosenberg","year":"1996","journal-title":"Contraception"},{"key":"2021121009361771000_B62","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2307\/2991663","article-title":"Breakage and acceptability of a polyurethane condom: A randomized, controlled study.","volume":"30","author":"Frezieres","year":"1998","journal-title":"Fam Plann Perspect"},{"key":"2021121009361771000_B63","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0002-9378(12)91813-X","article-title":"Long-acting injectable contraception with depot medroxyprogesterone acetate.","volume":"170","author":"Kaunitz","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"2021121009361771000_B64"},{"key":"2021121009361771000_B65","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1054-139X(94)00047-I","article-title":"The contraceptive use of Depo-Provera in US adolescents.","volume":"16","author":"Koenigs","year":"1995","journal-title":"J Adolesc Health"},{"key":"2021121009361771000_B66","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1542\/peds.94.5.687","article-title":"A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception.","volume":"94","author":"Cromer","year":"1994","journal-title":"Pediatrics"},{"key":"2021121009361771000_B67","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0932-8610(12)80157-5","article-title":"Medroxyprogesterone (Depo-Provera) use in adolescents: uterine bleeding and blood pressure patterns, patient satisfaction, and continuation rates.","volume":"8","author":"Smith","year":"1995","journal-title":"Adolesc Pediatr Gynecol"},{"key":"2021121009361771000_B68","first-page":"407","article-title":"Use of Depot Medroxyprogesterone acetate contraception in adolescents.","volume":"41","author":"Davis","year":"1996","journal-title":"J Reprod Med"},{"key":"2021121009361771000_B69","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1001\/jama.1995.03520340055036","article-title":"Depot- medroxyprogesterone acetate and breast cancer.","volume":"273","author":"Skegg","year":"1995","journal-title":"JAMA"},{"key":"2021121009361771000_B70","first-page":"3","article-title":"Breast disease and hormonal contraception: Resolution of a lasting controversy.","volume":"5","author":"Speroff","year":"1997","journal-title":"Diagn Contraception"},{"key":"2021121009361771000_B71","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0022-3476(96)70148-8","article-title":"A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.","volume":"129","author":"Cromer","year":"1996","journal-title":"J Pediatr"},{"key":"2021121009361771000_B72","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0889-8545(00)80011-X","article-title":"Update on adolescent contraception.","volume":"27","author":"Hewitt","year":"2000","journal-title":"Obstet Gynecol Clin North Am"},{"key":"2021121009361771000_B73","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1083-3188(00)86635-8","article-title":"Depo-Provera: an ideal contraceptive for adolescents?","volume":"12","author":"Boroditsky","year":"1999","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"2021121009361771000_B74","first-page":"4","article-title":"DMPA and bone density loss: an update.","volume":"5","author":"Grimes","year":"1999","journal-title":"The Contraception Report"},{"key":"2021121009361771000_B75","first-page":"87","article-title":"Sustained-release contraceptives.","volume":"13","author":"Darney","year":"1990","journal-title":"Curr Problems Obstet Fertil"},{"key":"2021121009361771000_B76","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJM199411033311806","article-title":"The use of levonorgestrel implants (Norplant) for contraception in adolescent mothers.","volume":"331","author":"Polaneczky","year":"1994","journal-title":"N Engl J Med"},{"key":"2021121009361771000_B77","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S1083-3188(00)86633-4","article-title":"Comparison of continuation rates for hormonal contraception among adolescents.","volume":"12","author":"Zibners","year":"1999","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"2021121009361771000_B78","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00006250-199102000-00018","article-title":"The significance of bleeding patterns in Norplant implant users.","volume":"77","author":"Shoupe","year":"1991","journal-title":"Obstet Gynecol"},{"key":"2021121009361771000_B79","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1542\/peds.92.2.257","article-title":"Patient satisfaction and side effects with levonorgestrel implant (Norplant) use in adolescents 18 years of age or younger.","volume":"92","author":"Berenson","year":"1993","journal-title":"Pediatrics"},{"key":"2021121009361771000_B80","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0002-9378(96)70326-5","article-title":"Hormonal treatment for bleeding in users of Norplant implants.","volume":"174","author":"Alvarez-Sanchez","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"2021121009361771000_B81","first-page":"1","article-title":"The intrauterine device.","volume":"164","author":"American College of Obstetricians and Gynecologists","year":"1992","journal-title":"ACOG Tech Bull"},{"key":"2021121009361771000_B82","first-page":"4","article-title":"Modern IUDs.","volume":"9","author":"Grimes","year":"1998","journal-title":"The Contraceptive Report"},{"key":"2021121009361771000_B83","first-page":"7","article-title":"IUD patient selection and practice guidelines.","volume":"5","author":"Nelson","year":"1998","journal-title":"Dialogues in Contraception"},{"key":"2021121009361771000_B84","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/jama.1996.03540140051026","article-title":"A 17-year old mother seeking contraception.","volume":"276","author":"Grimes","year":"1996","journal-title":"JAMA"},{"key":"2021121009361771000_B85","first-page":"1","article-title":"The IUD: Dispelling the myths and assessing the potential.","volume":"5","author":"Mishell","year":"1997","journal-title":"Dialogues in Contraception"},{"key":"2021121009361771000_B86","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0031-3955(05)70146-2","article-title":"The use of non-hormonal methods of contraception in adolescents.","volume":"46","author":"Rieder","year":"1999","journal-title":"Pediatr Clin North Am"},{"key":"2021121009361771000_B87","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2307\/2135434","article-title":"Helping teenagers postpone sexual involvement.","volume":"22","author":"Howard","year":"1990","journal-title":"Fam Plann Perspect"},{"key":"2021121009361771000_B88","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1080\/01614576.1995.11074158","article-title":"Sexuality education programs for youth: current state of affairs and strategies for the future.","volume":"21","author":"Greydanus","year":"1995","journal-title":"J Sex Educ Ther"},{"key":"2021121009361771000_B89","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1542\/peds.104.5.1161","article-title":"Contraception and adolescents.","volume":"104","author":"American Academy of Pediatrics, Committee on Adolescence","year":"1999","journal-title":"Pediatrics"},{"key":"2021121009361771000_B90","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/BF02845536","article-title":"Reproductive health: an international perspective.","volume":"66","author":"Greydanus","year":"1999","journal-title":"Ind J Pediatr"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/107\/3\/562\/891964\/562.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/107\/3\/562\/891964\/562.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T05:37:43Z","timestamp":1682746663000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/107\/3\/562\/66000\/Contraception-in-the-Adolescent-An-Update"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,3,1]]},"references-count":90,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2001,3,1]]},"published-print":{"date-parts":[[2001,3,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.107.3.562","relation":{},"ISSN":["1098-4275","0031-4005"],"issn-type":[{"value":"1098-4275","type":"electronic"},{"value":"0031-4005","type":"print"}],"subject":[],"published":{"date-parts":[[2001,3,1]]}}}